Routine Mammography Screening Increases Except Among Minorities and the Elderly

Publication
Article
OncologyONCOLOGY Vol 16 No 1
Volume 16
Issue 1

The number of women receiving mammograms is higher than ever, according to the results of a study conducted by the Board of Sponsors for National Breast Cancer Awareness Month (NBCAM). The study found that more women are getting

The number of women receiving mammograms is higher thanever, according to the results of a study conducted by the Board of Sponsors forNational Breast Cancer Awareness Month (NBCAM). The study found that more womenare getting annual mammograms and that cancer mortality rates are declining.

Despite this encouraging news, the study also found that minority and elderlywomen are far less likely to have regular screenings (every 1 or 2 years). Thistrend is reflected in the breast cancer mortality rates among black women, asthey are more likely to be diagnosed with breast cancer at a later, lesstreatable stage.

"We’ve come a long way from the time that breast cancer screening wasnot a test that women routinely had done, but we know that more needs to be doneto reach minority women," said National Breast Cancer Awareness MonthNational Coordinator Susan Nathanson. "While the efforts of NBCAM and ourmembers have contributed to the increase in mammography rates and subsequentdecrease in death rates, we all need to focus on helping minority andlower-income women understand the benefits of mammography screening and theresources that are available to them to practice good breast health."

Factors Affecting Screening

The study found that regular screening of minority women may be hindered bylow income, no insurance coverage, or lack of information. Overall, theproportion of women aged 40 years and older receiving mammograms rose steadily,from 58.3% in 1990 to 76.1% in 2000. "For the past 10 to 15 years, we havemade mammography available throughout this country to more and more women,"said Ellen Mendelson, MD, director of breast imaging at Northwestern MemorialHospital and professor of radiology at Northwestern University Medical School."However, we’re concerned that minority groups haven’t taken advantageof the opportunities that mammography can provide."

Moreover, the failure of physicians to discuss mammography with theirpatients may also be discouraging minority and elderly women from havingmammograms. Recommendation for mammography was found to be more frequent amongwomen who had a regular physician and health insurance. The study found thatsocioeconomic status, age, and other characteristics, excluding race andethnicity, were related to a physician recommendation for screening mammography.About 62% reported an adequate level of referrals for screening mammograms.

In addition, the shortage of diagnostic radiologists available to performmammograms, low reimbursement rates, and decline in the number of imagingcenters around the United States contribute to current and future access issues.Whether the closing of imaging centers and increased regulation to ensurequality services has significantly limited patient access to mammography remainsundetermined. The demand for routine or annual mammography will increase as thepopulation ages, and these issues must be monitored carefully to ensure thataccess to mammography is not put at risk.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.